Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2000
10/11/2000CN1057294C Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkycarboxylates and intermediates
10/11/2000CN1057293C N(1),N(2)-di (2,3-dihydroxy-4,6-disulfobenzyl) ethylene diamine chelant
10/11/2000CN1057292C Dicyclic compound, medicinal composition containing same and use thereof
10/11/2000CN1057231C Modulation of AIDS virus-related events by double-stuanded RNAs
10/11/2000CN1057217C Seabuckthorn fruit yolk health oil and its producing method
10/11/2000CN1057212C Oral liquor for body-building
10/11/2000CN1057207C Composition for treating osteoporosis
10/10/2000US6130348 Silylation of carbamate group to protect; alkylation with alkyllithium
10/10/2000US6130333 Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use
10/10/2000US6130326 L-ribavirin. oh; anticarcinogenic/antitumor agents; viricides; fungicides; treatment of autoimmune diseases
10/10/2000US6130254 Methods for inhibiting photoaging of skin
10/10/2000US6130252 Coconut diethanolamide, and coconut polydiethanolamide
10/10/2000US6130250 Veterinary use of a pleuromutilin derivative
10/10/2000US6130249 Solid compositions suitable for oral administration comprising L-carnitine and alkanoyl-L-carnitine magnesium tartrate
10/10/2000US6130248 Tricarboxylic acid-containing oxyalkyl esters and uses thereof
10/10/2000US6130245 Dinuclear platinum complexes as cisplatin analogs for cancer treatment
10/10/2000US6130244 Product and method to reduce stress induced immune suppression
10/10/2000US6130242 S-procyclidine for treating urinary incontinence
10/10/2000US6130241 Insect-repellent formulations
10/10/2000US6130240 Compound for treatment of cardiac arrhythmia, synthesis, and methods of use
10/10/2000US6130239 Inhibit cyclin-dependent kinases
10/10/2000US6130234 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
10/10/2000US6130233 Methods and compositions for treating allergic disorders and other disorders using metabolic derivatives of astemizole
10/10/2000US6130231 Integrin receptor antagonists
10/10/2000US6130230 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
10/10/2000US6130228 Alzheimers
10/10/2000US6130227 7-Substituted camptothecin derivatives and methods for inhibiting the growth of tumor cells therewith
10/10/2000US6130226 Immunotherapeutic agents
10/10/2000US6130223 Thienopyrimidine with phosphodiesterase V inhibiting effect
10/10/2000US6130222 Analgesics
10/10/2000US6130221 Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions
10/10/2000US6130219 Drug resistance and multidrug resistance modulators
10/10/2000US6130218 High blood pressure
10/10/2000US6130216 Use of thiazolidinedione derivatives in the treatment of insulin resistance
10/10/2000US6130215 Central nervous system
10/10/2000US6130210 Heparin derivatives having antimetastatic activity
10/10/2000US6130208 Formulation containing a nucleotide analogue
10/10/2000US6130205 Method for determining susceptibility to Escherichia coli urinary tract infections, method for diagnosing secretors and nonsecretors, and method and medicament for preventing Escherichia coli urinary tract infections
10/10/2000US6130201 Modulation of BCL-2 phosphorylation
10/10/2000US6130088 Antisense modulation of telomeric repeat binding factor 1 expression
10/10/2000US6130072 Preparing and recovering enzyme inhibitor from bacterial cultures
10/10/2000US6130060 Gene encoding for adseverin
10/10/2000US6130053 Method for selecting compounds for inhibition of neoplastic lesions
10/10/2000US6130052 Leukemia associated genes
10/10/2000US6129944 Product containing a microcrystalline plant sterol, a sweetening agent and water; edible spread made of product and berry or fruit; lowering cholesterol by administering product
10/10/2000US6129933 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
10/10/2000US6129932 Compositions for inhibiting platelet aggregation
10/10/2000US6129930 Without causing treatment-limiting elevations in uric acid levels and/or glucose levels, by orally administering an antihyperlipidemic amount of niacin and an excipient to provide sustained release; fda orange book listed patent for niacin and simvastatin
10/10/2000US6129925 Container filled with infusion liquids and infusion preparation
10/10/2000US6129917 Immunogenic compositions comprising porphyromonas gingivalis proteins and/or peptides and methods
10/10/2000US6129910 Water-insoluble noncrosslinked bile acid sequestrants
10/10/2000CA2265194C A method of testing the purity of lamotrigine
10/10/2000CA2183415C A new skin preparation composition
10/10/2000CA2147606C Stable extended release oral dosage composition
10/10/2000CA2126648C Liposomes containing bioavailable iron (ii) and method for obtaining them
10/10/2000CA2117371C Cholesterol-lowering drug
10/10/2000CA2080231C 2'-o-alkylnucleotides as well as polymers which contain such nucleotides
10/10/2000CA2067475C Carbostyril derivatives and their use
10/10/2000CA2056421C Agent against autoimmune diseases
10/10/2000CA2030516C Parathyroid hypertensive factor
10/10/2000CA2028893C Morpholinols, their prepation and use
10/10/2000CA1341114C Pharmaceutical formulations containing melphalan hydrochloride
10/09/2000CA2310990A1 A use of galantamine for the treatment of alzheimer's disease; targeting the underlying cause of the disease
10/09/2000CA2268462A1 Method of preventing necrosis and apoptosis
10/08/2000CA2303752A1 Renal cell carcinoma treatment
10/07/2000CA2304127A1 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
10/07/2000CA2303721A1 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
10/05/2000WO2000058733A2 Assay for testing the efficacity of a therapy
10/05/2000WO2000058523A1 Glucocorticoid receptor agonist and decreased pp5
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058512A1 Antisense modulation of interleukin-5 signal transduction
10/05/2000WO2000058511A1 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3)
10/05/2000WO2000058506A2 Susceptibility to psoriasis
10/05/2000WO2000058496A1 50 human secreted proteins
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058475A2 Streptococcus pneumoniae antigens
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058469A1 48 human secreted proteins
10/05/2000WO2000058460A2 Casb619 involved in colon cancers
10/05/2000WO2000058455A2 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058344A1 Proteins modified by xanthurenic acid
10/05/2000WO2000058339A2 50 human secreted proteins
10/05/2000WO2000058337A1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
10/05/2000WO2000058328A2 Avermectin derivatives
10/05/2000WO2000058321A1 Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same
10/05/2000WO2000058318A1 Phosphate containing macrocyclic immunomodulators
10/05/2000WO2000058314A2 Sulfamate containing macrocyclic immunomodulators
10/05/2000WO2000058313A1 4-substituted quinoline derivatives as gaba receptor ligands
10/05/2000WO2000058312A1 Compounds capable of cleaving double-stranded dna and method of utilization of the same
10/05/2000WO2000058311A1 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics
10/05/2000WO2000058309A1 Derivatives of pyrimido[6,1-a]isoquinolin-4-one
10/05/2000WO2000058308A1 DERIVATIVES OF PYRIMIDO[6,1-a]ISOQUINOLIN-4-ONE
10/05/2000WO2000058307A2 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058303A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
10/05/2000WO2000058296A1 Protease inhibitors
10/05/2000WO2000058295A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000WO2000058294A1 Antibacterial agents
10/05/2000WO2000058293A2 Glucokinase activators
1 ... 6232 6233 6234 6235 6236 6237 6238 6239 6240 6241 6242 6243 6244 6245 6246 6247 6248 6249 6250 6251 6252 ... 7860